FinTrust Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.46K | Hold |
|
|||||
|
2024
Q2 | $9.72K | Hold |
|
|||||
|
2024
Q1 | $12.3K | Hold |
|
|||||
|
2023
Q4 | $11.3K | Hold |
|
|||||
|
2023
Q3 | $8.17K | Sell |
|
|||||
|
2023
Q2 | $22.6K | Hold |
|
|||||
|
2023
Q1 | $22.6K | Hold |
|
|||||
|
2022
Q4 | $22.6K | Hold |
|
|||||
|
2022
Q3 | $32K | Sell |
|
|||||
|
2022
Q2 | $73K | Hold |
|
|||||
|
2022
Q1 | $60K | Sell |
|
|||||
|
2021
Q4 | $2.12M | Buy |
|
|||||
|
2021
Q3 | $2.89M | Sell |
|
|||||
|
2021
Q2 | $4.21M | Buy |
|
|||||
|
2021
Q1 | $3.03M | Sell |
|
|||||
|
2020
Q4 | $3.86M | Buy |
|
|||||
|
2020
Q3 | $2.04K | Sell |
|
|||||
|
2020
Q2 | $1.92M | Buy |
|
|||||
|
2020
Q1 | $48K | Sell |
|
|||||
|
2019
Q4 | $75K | Hold |
|
|||||
|
2019
Q3 | $51K | Buy |
|